About PharmaCielo
PharmaCielo is a company based in Toronto (Canada) founded in 2014. PharmaCielo has raised $16.44 million across 10 funding rounds. PharmaCielo has completed 2 acquisitions, including Creso Pharma and Ubiquo Telemedicina. PharmaCielo offers products and services including CBD Isolate, Medicinal Flower, and Cannabis Extracts. PharmaCielo operates in a competitive market with competitors including Canopy Growth, Organigram, Cannara Biotech, C21 Investments and Aphria, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Agriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmacielo Ltd.
-
Annual Revenue
$2.2 M (USD)89.55as on Mar 31, 2025
-
Net Profit
-$6.32 M (USD)48.6as on Mar 31, 2025
-
EBITDA
-$2.31 M (USD)66.51as on Mar 31, 2025
-
Total Equity Funding
$16.44 M (USD)
in 10 rounds
-
Latest Funding Round
$10 M (USD), Post-IPO
Nov 03, 2020
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Creso Pharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PharmaCielo
PharmaCielo is a publicly listed company on the OTC with ticker symbol PCLOF in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PharmaCielo
PharmaCielo offers a comprehensive portfolio of products and services, including CBD Isolate, Medicinal Flower, and Cannabis Extracts.
Pure CBD refined for precise medicinal and pharmaceutical applications.
High-quality cannabis flower grown for reliable pharmaceutical use.
Processed extracts for consistent, safe medicinal applications.
People of PharmaCielo
Unlock access to complete
Funding Insights of PharmaCielo
PharmaCielo has successfully raised a total of $16.44M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by PharmaCielo
PharmaCielo has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Creso Pharma and Ubiquo Telemedicina.
Investment portfolio details for PharmaCielo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabinoid therapeutics are developed for human and veterinary health applications.
|
Locked | Locked | 2015 | Locked | |
|
Web platforms for telemedicine, workflow, and image management are provided.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for PharmaCielo
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - PharmaCielo
Detailed financials for PharmaCielo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmacielo Comparisons
Peer comparison for PharmaCielo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PharmaCielo
PharmaCielo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Canopy Growth, Organigram, Cannara Biotech, C21 Investments and Aphria, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cannabis products are provided to support consumer wellness and health.
|
|
| Locked | Locked | Locked |
Provider of cannabis products, brands, and international business development investments
|
|
| Locked | Locked | Locked |
Medicinal cannabis cultivation facility
|
|
| Locked | Locked | Locked |
Cannabis and hemp-derived products are cultivated, processed, and supplied.
|
|
| Locked | Locked | Locked |
Cannabis-derived nutritional and wellness products are provided by Aphria.
|
Detailed competitors of PharmaCielo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmacielo
Complete news archive for PharmaCielo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmaCielo
PharmaCielo was founded in 2014 and raised its 1st funding round 1 year after it was founded.
PharmaCielo is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Marc Lustig is the current CEO of PharmaCielo.
PharmaCielo is a funded company, having raised a total of $16.44M across 10 funding rounds to date.
Annual revenue of PharmaCielo is $2.2M as on Mar 31, 2025.
PharmaCielo was founded in 2014 and is headquartered in Toronto, Canada. Operations focus on the cultivation and marketing of medicinal cannabis in Colombia, where proprietary strains are grown under controlled indoor environments. Cannabis flowers are processed to extract oil and manufacture pharmaceutical-grade products for the health sector.
PharmaCielo's top competitors include Canopy Growth, Organigram and Cannara Biotech.
PharmaCielo offers CBD Isolate, Medicinal Flower, and Cannabis Extracts.
Yes, PharmaCielo is publicly traded on OTC under the ticker symbol PCLOF.
PharmaCielo has made 2 acquisitions, including Creso Pharma, and Ubiquo Telemedicina.
The ticker symbol of PharmaCielo is PCLOF on OTC.